Audio Sources - Full Text Articles

Exclusive: Reckitt expects U.S. infant formula shortage until spring


The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to “persist” until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.

Panicked parents had earlier this year emptied the baby formula aisles at supermarkets after former top U.S. manufacturer Abbott Laboratories (ABT.N) in February recalled dozens of types of its Similac, Alimentum and EleCare formulas.

The products, made at a plant in Michigan, were pulled after complaints of bacterial infections.

Supermarkets like Target (TGT.N) and Walgreens Boots Alliance (WBA.O) were forced to limit its sales, putting pressure on the Biden administration to address the crisis.

The White House in May took steps to address the shortage, invoking the Defense Production Act to help manufacturers obtain the ingredients needed to ramp up supply.

Supplies are yet to return to normal since the peak of the crisis in May and June, despite the U.S. making progress in replenishing stocks, said Robert Cleveland, Reckitt senior vice president, North America and Europe Nutrition.

“I suspect that will persist to some degree until the spring resets,” he said. “When we talk about the crisis we talk about the condition of the shelves and how they appear to consumers, and how well that shelf meets their needs.”

Rival manufacturer Perrigo Company Plc (PRGO.N) declined to comment, while Danone, maker of Aptamil, did not immediately respond to a request for comment.

Since the Abbott recall, share of Reckitt in the infant formula market has skyrocketed, making it the No.1 supplier in the United States.

The British company has yet to see its newfound popularity recede as Cleveland said its just over 50% of the market has “remained relatively unchanged” since earlier this year.

Its top position has been further boosted by the United States saying it will temporarily cover the cost of baby formula for low-income families dependent on government discounts in states contracted with the company.

Companies normally bid for state contracts to be the sole provider of baby formula for low-income families under the Women, Infants and Children (WIC) programme. In their bids, they offer a “rebate” in the form of discounts to the states.

The government’s intervention, aimed at incentivising firms to boost supplies effectively covers that rebate.

Reckitt has said its formula factories are operating 24/7, and it was feeding more than 40% of all low-income WIC infants.

“Certainly at some point in the future, we expect they (the United States Department of Agriculture) will want to return the programme to normal,” Cleveland said.

“What we’re telling them is to give us enough notice – to put, essentially, a date on the calendar….don’t try to shock the system by making it happen too quickly – give us time to adjust because we’ll have to adjust our production, we’ll have to adjust our distribution,” he said.

Related Galleries:

Mead Johnson’s product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. REUTERS/Brendan McDermid

Enfamil baby formula, produced by Mead Johnson, is seen in a supermarket as inflation continues to hit consumers amid continuing nationwide shortages in infant and toddler formula, in Los Angeles, California, U.S. May 27, 2022. REUTERS/Lucy Nicholson

Mead Johnson’s product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. REUTERS/Brendan McDermid